| CL1991B |
|
2805804-54-8 |
CP-547632 TFA
CP-547632 TFA
-
98+%
|
需詢價 |
C20H24BrF2N5O3S·C2HF3O2 |
|
|
|
| CL2879A |
|
210644-62-5 |
(Z)-奧蘭替尼 | (Z)-SU6668 | (Z)-TSU-68
(Z)-Orantinib | (Z)-SU6668 | (Z)-TSU-68
-
98+%
|
需詢價 |
C18H18N2O3 |
|
|
|
| CL2509 |
|
1013920-15-4 |
伏羅尼布
Vorolanib (X-82,CM082)
3-5days
98+%
|
￥850.00 |
C23H26FN5O3 |
|
|
|
| CL2424 |
|
557795-19-4 |
舒尼替尼 | 舒尼替尼堿
Sunitinib | Sunitinib Base
In-stock
99+%
|
￥466.00 |
C22H27FN4O2 |
|
|
|
| CLA1267 |
|
1024603-92-6 |
艾蘆庫單抗
Icrucumab (Anti-VEGFR1 / FLT1)
3-5days
95+%
|
￥2500.00 |
— |
|
|
|
| CLA1179 |
|
934216-54-3 |
阿拉賽珠單抗
Alacizumab (Anti-VEGFR2 / KDR / CD309)
3-5days
95+%
|
￥4000.00 |
— |
|
|
|
| CL2214 |
|
215543-92-3 |
SU 5402 | SU-5402
(Z)-3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid.
In-stock
98+%
|
￥550.00 |
C17H16N2O3 |
|
|
|
| CL1633 |
|
417716-92-8 |
樂伐替尼 | 侖伐替尼 | 樂法替尼 | E7080
Lenvatinib | E7080
-
98+%
|
需詢價 |
C21H19ClN4O4 |
|
|
|
| CL1637 |
|
319460-85-0 |
阿西替尼,阿昔替尼
Axitinib (AG-013736)
In-stock
98+%
|
￥588.00 |
C22H18N4OS |
|
|
|
| CLA1018 |
|
947687-13-0 |
雷莫蘆單抗
Ramucirumab; LY3009806; IMC-1121B
3-5days
98+%
|
￥2000.00 |
— |
|
|
|
| CLA1008 |
|
216974-75-3 |
貝伐單抗
Bevacizumab (anti-VEGF) | RhuMab VEGF
3-5days
95+%
|
￥1500.00 |
— |
|
|
|
| CL1991 |
|
252003-65-9 |
CP-547632
CP-547632 | PAN-90806 | CP-632 | OSI-632
3-5days
98+%
|
￥366.00 |
C20H24BrF2N5O3S |
|
|
|
| CL1906 |
|
212141-51-0 |
瓦他拉尼二鹽酸鹽
Vatalanib Dihydrochloride; Vatalanib 2HCl
In-stock
98+%
|
￥458.00 |
C20H17Cl3N4 |
|
|
|
| HL1306 |
|
568-72-9 |
丹參酮IIA
Tanshinone IIA | Dan Shen Ketone
-
98+%
|
需詢價 |
C19H18O3 |
|
|
|
| CL2329 |
|
857890-39-2 |
甲磺酸樂伐替尼 | 侖伐替尼甲酸鹽
Lenvatinib Mesylate | E7080 mesylate | ER-203492-00 | Lenvima
-
Purity: 99.72%
|
需詢價 |
C21H19ClN4O4.CH4O3S |
|
|
|
| CL2355A |
|
649735-63-7 |
丙氨酸布立尼布
Brivanib Alaninate | BMS-582664
3-5days
98+%
|
￥636.00 |
C22H24FN5O4 |
|
|
|
| CL2355 |
|
649735-46-6 |
布立尼布
Brivanib | BMS-540215
3-5days
98+%
|
￥636.00 |
C19H19FN4O3 |
|
|
|
